» Articles » PMID: 14656923

Transplantation of Bone Marrow-derived Mononuclear Cells in Ischemic Apolipoprotein E-knockout Mice Accelerates Atherosclerosis Without Altering Plaque Composition

Abstract

Background: Bone marrow-derived mononuclear cells (BM-MNCs) enhance postischemic neovascularization, and their therapeutic use is currently under clinical investigation. We evaluated the safety of BM-MNC-based therapy in the setting of atherosclerosis.

Methods And Results: Apolipoprotein E (apoE)-knockout (KO) mice were divided into 4 groups: 20 nonischemic mice receiving intravenous injection of either saline (n=10) or 10(6) BM-MNCs from wild-type animals (n=10) and 20 mice with arterial femoral ligature receiving intravenous injection of either saline (n=10) or 10(6) BM-MNCs from wild-type animals (n=10) at the time of ischemia induction. Animals were monitored for 4 additional weeks. Atherosclerosis was evaluated in the aortic sinus. BM-MNC transplantation improved tissue neovascularization in ischemic hind limbs, as revealed by the 210% increase in angiography score (P<0.0001), the 33% increase in capillary density (P=0.01), and the 65% increase in tissue Doppler perfusion score (P=0.0002). Hindlimb ischemia without BM-MNC transplantation or BM-MNC transplantation without ischemia did not affect atherosclerotic plaque size. However, transplantation of 10(6) BM-MNCs into apoE-KO mice with hindlimb ischemia induced a significant 48% to 72% increase in lesion size compared with the other 3 groups (P=0.0025), despite similar total cholesterol levels. Transplantation of 10(5) BM-MNCs produced similar results, whereas transplantation of 10(6) apoE-KO-derived BM-MNCs had neither proangiogenic nor proatherogenic effects. There was no difference in plaque composition between groups.

Conclusions: BM-MNC therapy is unlikely to affect atherosclerotic plaque stability in the short term. However, it may promote further atherosclerotic plaque progression in an ischemic setting.

Citing Articles

Systematic review and meta-analysis of the effect of bone marrow-derived cell therapies on hind limb perfusion.

van Rhijn-Brouwer F, Wever K, Kiffen R, van Rhijn J, Gremmels H, Fledderus J Dis Model Mech. 2024; 17(5).

PMID: 38616715 PMC: 11139036. DOI: 10.1242/dmm.050632.


Transcoronary stem cell transfer and evolution of infarct-related artery atherosclerosis: evaluation with conventional and novel imaging techniques including Quantitative Virtual Histology (qVH).

Dabrowski W, Tekieli L, Mazurek A, Lanocha M, Banys R, Zmudka K Postepy Kardiol Interwencyjnej. 2023; 18(4):483-495.

PMID: 36967840 PMC: 10031661. DOI: 10.5114/aic.2023.125609.


Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis.

Coppin E, Zhang X, Ohayon L, Johny E, Dasari A, Zheng K Arterioscler Thromb Vasc Biol. 2023; 43(6):889-906.

PMID: 36891902 PMC: 10213134. DOI: 10.1161/ATVBAHA.123.318956.


Endothelial Progenitor Cells in Coronary Artery Disease: From Bench to Bedside.

Pelliccia F, Zimarino M, De Luca G, Viceconte N, Tanzilli G, De Caterina R Stem Cells Transl Med. 2022; 11(5):451-460.

PMID: 35365823 PMC: 9154346. DOI: 10.1093/stcltm/szac010.


Extracorporeal Cardiac Shock Waves Therapy Improves the Function of Endothelial Progenitor Cells After Hypoxia Injury Activating PI3K/Akt/eNOS Signal Pathway.

Wang M, Yang D, Hu Z, Shi Y, Ma Y, Cao X Front Cardiovasc Med. 2021; 8:747497.

PMID: 34708093 PMC: 8542843. DOI: 10.3389/fcvm.2021.747497.